Pharmaceutical Industry
Pharmaceutical Manufacturing: GMP, Process Reliability, and Data Integrity on a Validated Platform
Pharmaceutical manufacturing operates under the most demanding manufacturing-validation regime of any industry, with data-integrity obligations and process-validation requirements that no operator can satisfy with parallel paper-based systems. TMG implements PeakAvenue's eQMS, Process Reliability, and quality-management platform for pharmaceutical manufacturers operating under FDA 21 CFR Part 211, EU GMP, ICH Q9 / Q10, and the GAMP 5 computerised-system validation framework that anchors every regulated software deployment in this industry.
Built for the regulatory frame that anchors pharmaceutical manufacturing
The methodology we deliver is configured against the working set of standards that govern pharmaceutical Good Manufacturing Practice, validation, data integrity, and the international harmonisation framework that underpins global pharmaceutical trade.
The challenges we address
Process validation lifecycle consumes engineering capacity
Process Performance Qualification, continued process verification, and the broader process-validation lifecycle absorb engineering and quality time that should reach the product. Without structured tooling for the protocol, the execution evidence, and the continued-verification trail, the validation cycle becomes a multi-week internal scramble at every regulatory milestone.
Data-integrity obligations exceed paper-based capacity
ALCOA+ data-integrity requirements (Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, Available) cannot be met reliably by paper batch records and orphan spreadsheets. The MHRA, FDA, and EMA findings track that gap year after year, and the remediation is structural rather than cosmetic.
Quality risk management runs disconnected from operations
ICH Q9 frames quality risk management as a lifecycle discipline that connects to design, manufacturing, change control, and supplier qualification. In most operations, the risk-management activities run as parallel paperwork that the operations team does not see, and the integration the standard expects does not happen.
GAMP 5 validation effort drives implementation cost
Validating GxP software under the GAMP 5 framework is rigorous by design. Documentation, traceability, and compliance evidence absorb engineering and quality time that would otherwise reach the product itself, and the validation effort frequently dominates the implementation cost rather than the software itself.
An eQMS that satisfies the auditor and supports the manufacturing team
TMG configures, validates, and operationalises the PeakAvenue platform for pharmaceutical manufacturing workflows, with the GAMP 5 validation deliverables built into the engagement, not bolted on after.
GAMP 5-compliant eQMS implementation
TMG delivers PeakAvenue's eQMS with the full validation documentation set required for GxP environments. The system is configured for pharmaceutical manufacturing workflows and meets EU GMP, ICH Q10, and FDA 21 CFR Part 11 requirements out of the box, with the validation package as a deliverable rather than a separate project.
ICH Q9 quality risk management as a lifecycle discipline
FMEA, hazard analysis, risk ranking, and the broader quality risk management toolkit operate on the same platform that runs production. Risks attach to design inputs, validation criteria, change-control records, and supplier qualifications across the product lifecycle, satisfying ICH Q9 linkage requirements without parallel record-keeping.
Document control for SOPs, batch records, and master files
A central, version-controlled document management system holds master batch records, SOPs, validation protocols, and submission-supporting documents under one structure. The audit trail is continuous and electronically signable; the data-integrity obligations under ALCOA+ are met by construction rather than by reconstruction.
Process reliability and continued process verification
The Isograph Process Reliability module on the Availability Workbench platform addresses the reliability and availability of pharmaceutical manufacturing equipment as a lifecycle programme. Process Performance Qualification, continued process verification, and the broader process-validation lifecycle integrate with the maintenance and reliability programme rather than running as parallel deliverables.
Supplier quality and supply-chain traceability
Active pharmaceutical ingredient suppliers, excipient suppliers, contract manufacturers, and the broader pharmaceutical supply chain are managed on the same eQMS that runs the manufacturing operation. Supplier qualification, change-control, and ongoing performance monitoring live on a connected data model, with the supplier audit trail integrated into the inspection-ready record.
What pharmaceutical manufacturing sites have realised
The descriptors below characterise the typical outputs of a TMG pharmaceutical engagement. Depth in any given engagement scales with the size of the operation, the maturity of the existing reliability and quality programme, and the regulatory exposure of the operator.
Engage TMG for your Pharmaceutical programme
The Mantua Group implements PeakAvenue's eQMS, FMEA, Process Reliability, and supply-chain platform for pharmaceutical manufacturers operating under FDA 21 CFR Part 211, EU GMP, ICH Q9 / Q10, and the GAMP 5 framework. We bring the analytical rigour, the regulatory familiarity, and the implementation discipline that turns a software platform into a working pharmaceutical quality system.